George Weinstock, co-director of the Human Genome Sequencing Center at Baylor College of Medicine, wrote a short, interesting article posted to MIT’s Tech Review, contemplating whether this year may be remembered as the year of the personalized genome.

In April, two companies, 454 Life Sciences and Illumina, announced plans to sequence individual human genomes. While genotyping tests have been used for decades to sequence single genes, DNA sequencing has never been done on the entire genome of a single person.